Pharmacologic rationale for treating allergic and nonallergic rhinitis

Area of Science:

• Allergy and Immunology
• Pharmacology
• Otolaryngology

Background:

• Allergic rhinitis (AR) and perennial nonallergic rhinitis (PNAR) are prevalent conditions with overlapping symptoms.
• AR diagnosis relies on specific IgE reactivity, while PNAR lacks identifiable allergic triggers.
• Effective management strategies are crucial for improving patient quality of life.

Purpose of the Study:

• To review current pharmacologic treatment options for AR and PNAR.
• To describe stepped-care algorithms for rhinitis pharmacotherapy.
• To provide a comprehensive guide for clinicians managing rhinitis.

Main Methods:

• Literature review of pharmacologic agents for rhinitis.
• Analysis of treatment guidelines and clinical trial data.
• Synthesis of information on intranasal corticosteroids, antihistamines, decongestants, and other agents.

Main Results:

• A wide array of pharmacologic agents are available for AR and PNAR.
• Includes intranasal corticosteroids, H1-antihistamines, decongestants, cromolyn sodium, antileukotrienes, anticholinergics, capsaicin, anti-IgE, and intranasal saline.
• Stepped-up and stepped-down pharmacotherapeutic algorithms are presented.

Conclusions:

• Pharmacologic interventions offer diverse options for managing AR and PNAR.
• Tailored treatment algorithms can optimize patient outcomes.
• Further research may refine therapeutic approaches for rhinitis.